Sign Up Now to Download a Free Research Report on CBRX
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Columbia Laboratories, Inc.
Columbia Laboratories shares fell 40 percent last Friday after it was reported the FDA declined Watson Pharmaceuticals formal dispute-resolution request, which was filed in August, related to its New Drug Application for Prochieve.
Going forward ... (see research report)
Subscribe to News Feeds